Ultragenyx Pharmaceutical
RARE
#4444
Rank
NZ$3.95 B
Marketcap
NZ$41.04
Share price
3.83%
Change (1 day)
-49.12%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: NZ$3.95 Billion

As of February 2026 Ultragenyx Pharmaceutical has a market cap of NZ$3.95 Billion. This makes Ultragenyx Pharmaceutical the world's 4444th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.95 B-30.48%
2025NZ$5.69 B-19.89%
2024NZ$7.10 B14.5%
2023NZ$6.20 B21.37%
2022NZ$5.11 B-39.04%
2021NZ$8.39 B-33.88%
2020NZ$12.69 B246.03%
2019NZ$3.66 B11.26%
2018NZ$3.29 B18.54%
2017NZ$2.78 B-32.94%
2016NZ$4.14 B-34.92%
2015NZ$6.37 B256.34%
2014NZ$1.78 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

NZ$3.95 Billion
by Nasdaq info icon info icon
NZ$3.95 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
NZ$0.85 B-78.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.35 B-65.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$7.45 B 88.25%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$18.55 B 368.64%๐Ÿ‡บ๐Ÿ‡ธ USA